# ARRB2

## Overview
ARRB2, or arrestin beta 2, is a gene that encodes a multifunctional protein involved in the regulation of G protein-coupled receptor (GPCR) signaling. The protein arrestin beta 2, categorized as a regulatory protein, plays a pivotal role in cellular signaling by binding to phosphorylated GPCRs, thereby facilitating receptor desensitization and internalization. This process is crucial for modulating receptor activity and ensuring precise cellular responses to external stimuli (Reiter2017βarrestin). Beyond its role in GPCR signaling, arrestin beta 2 acts as a scaffold for various intracellular signaling pathways, influencing processes such as immune response, cell communication, and receptor recycling (Walker2003βArrestin2). The gene's expression and function have significant implications in various physiological and pathological contexts, including substance use disorders, cancer, and cardiovascular diseases, highlighting its potential as a therapeutic target and biomarker (Ikeda2006Possible; Bae2021βarrestin).

## Structure
ARRB2, or arrestin beta 2, is a protein involved in G protein-coupled receptor (GPCR) signaling. The primary structure of ARRB2 consists of a sequence of amino acids that form a semi-bisymmetric soluble protein (Peterson2017The). Its secondary structure includes 20 beta strands that create two beta-strand sandwich structures, connected by a short hinge domain (Peterson2017The). The tertiary structure of ARRB2 features a two-domain fold with N and C lobes, each forming a β-stranded sandwich structure connected by a hinge region (Hilger2018Structure). The protein also contains a conserved polar core, which plays a central role in GPCR interaction (Peterson2017The).

ARRB2 can form quaternary structures, such as dimers, at physiological levels (Peterson2017The). Specific domains include the N-terminal arm, finger loop/motif II, phosphate sensor, hinge domain, gate loop, and C-terminal arm, each contributing to its function in receptor binding and activation (Peterson2017The). Common post-translational modifications include phosphorylation, which affects its function and interactions (Hilger2018Structure). The presence of splice variant isoforms may alter its structure and function, although specific details are not provided in the context.

## Function
ARRB2, or arrestin beta 2, is a protein that plays a crucial role in the regulation of G protein-coupled receptor (GPCR) signaling. It functions by binding to phosphorylated receptors, which leads to the termination of G protein coupling, a process known as homologous desensitization. This action prevents further G protein interaction, thereby modulating receptor activity (Reiter2017βarrestin). ARRB2 also facilitates receptor internalization by interacting with components of the endocytic machinery, such as clathrin and AP2, and acts as a scaffold for various signaling pathways, including MAPK modules. This scaffolding role influences the activation of ERK, JNK, and p38 signaling pathways (Reiter2017βarrestin).

In the context of immune response, ARRB2 is involved in the regulation of T cell migration, particularly in the development of allergic asthma. It acts as a scaffold linking GPCR activation to MAPK cascades, which is crucial for the chemotaxis of T cells (Walker2003βArrestin2). Additionally, ARRB2 is active in the cytoplasm and at the cell membrane, influencing processes like cell communication, receptor recycling, and signal transduction, impacting various physiological responses (Reiter2017βarrestin).

## Clinical Significance
Mutations and alterations in the ARRB2 gene have been implicated in various diseases and conditions. In the context of substance use disorders, specific single nucleotide polymorphisms (SNPs) in ARRB2, such as rs1045280, rs2036657, and rs4790694, have been associated with methamphetamine use disorder, but not schizophrenia, suggesting a role in the pathophysiology of methamphetamine addiction (Ikeda2006Possible). ARRB2 is also linked to nicotine dependence, particularly in European American populations, where SNP rs4790694 shows significant associations with nicotine dependence measures (Sun2007βArrestins).

In cancer, ARRB2 expression levels are significant in glioblastoma, where high expression correlates with decreased HIF-1α levels, suggesting a potential antitumorigenic effect and a role as a biomarker for prognosis (Bae2021βarrestin). In opioid use disorder, ARRB2 variants, such as rs1045280, are associated with the consequences of chronic heroin use, indicating a protective role against adverse outcomes (Karavidha2021β‐Arrestin).

ARRB2 also influences the response to methadone maintenance treatment in opioid-dependent patients, with certain haplotypes linked to nonresponse, highlighting its role in opioid signal transduction and treatment variability (Oneda2010βArrestin2). In major depressive disorder, ARRB2 polymorphisms are associated with antidepressant treatment response, suggesting its involvement in the pharmacogenetics of depression (Petit2018The).

## Interactions
ARRB2 (arrestin beta 2) is involved in various protein interactions that play significant roles in cellular signaling and regulatory mechanisms. It interacts with the oncoprotein MDM2, a relationship that is enhanced by the activation of G-protein-coupled receptors (GPCRs). This interaction negatively regulates MDM2's function in p53 degradation, thereby restoring p53 levels in cells (Wang2003βArrestin).

ARRB2 also interacts with components of the ribosomal biogenesis machinery in the nucleus, such as nucleophosmin (NPM1), MDM2, and fibrillarin (FBL), following TRPV1 activation. This interaction suggests a role in regulating ribosomal RNA transcription and possibly other nucleolar functions (Hassan2021TRPV1). The interaction with TCOF1, a nucleolar phosphoprotein, indicates ARRB2's involvement in ribosomal biogenesis and its potential role in nociceptor sensitization (Hassan2021TRPV1).

In cardiac ischemia-reperfusion injury, ARRB2 interacts with the regulatory subunit of PI3K (p85-PI3K), inhibiting the formation of the p85-PI3K-CaV3 complex, which is crucial for activating the PI3K-Akt-GSK3b pathway. This interaction suggests ARRB2's role in mediating cardiomyocyte death during such injuries (Wang2017βarrestin).

ARRB2 also participates in nucleocytoplasmic shuttling, interacting with JNK3 kinase. The nuclear export signal (NES) in ARRB2 is crucial for retaining JNK3 in the cytoplasm, highlighting its role in cellular signaling pathways (Scott2002Differential).


## References


[1. (Wang2003βArrestin) Ping Wang, Hua Gao, Yanxiang Ni, Beibei Wang, Yalan Wu, Lili Ji, Linhua Qin, Lan Ma, and Gang Pei. Β-arrestin 2 functions as a g-protein-coupled receptor-activated regulator of oncoprotein mdm2. Journal of Biological Chemistry, 278(8):6363–6370, February 2003. URL: http://dx.doi.org/10.1074/jbc.m210350200, doi:10.1074/jbc.m210350200. This article has 115 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.m210350200)

[2. (Hassan2021TRPV1) Ahmed Hassan, Mircea Iftinca, Daniel Young, Robyn Flynn, Francina Agosti, Nasser Abdullah, Manon Defaye, Mark G. H. Scott, Antoine Dufour, and Christophe Altier. Trpv1 activation promotes β-arrestin2 interaction with the ribosomal biogenesis machinery in the nucleolus: implications for p53 regulation and neurite outgrowth. International Journal of Molecular Sciences, 22(5):2280, February 2021. URL: http://dx.doi.org/10.3390/ijms22052280, doi:10.3390/ijms22052280. This article has 0 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/ijms22052280)

[3. (Hilger2018Structure) Daniel Hilger, Matthieu Masureel, and Brian K. Kobilka. Structure and dynamics of gpcr signaling complexes. Nature Structural &amp; Molecular Biology, 25(1):4–12, January 2018. URL: http://dx.doi.org/10.1038/s41594-017-0011-7, doi:10.1038/s41594-017-0011-7. This article has 911 citations.](https://doi.org/10.1038/s41594-017-0011-7)

[4. (Karavidha2021β‐Arrestin) Klevis K. Karavidha, Margit Burmeister, and Mark K. Greenwald. Β‐arrestin 2 (arrb2) polymorphism is associated with adverse consequences of chronic heroin use. The American Journal on Addictions, 30(4):351–357, March 2021. URL: http://dx.doi.org/10.1111/ajad.13150, doi:10.1111/ajad.13150. This article has 7 citations.](https://doi.org/10.1111/ajad.13150)

[5. (Ikeda2006Possible) M. Ikeda, N. Ozaki, T. Suzuki, T. Kitajima, Y. Yamanouchi, Y. Kinoshita, T. Kishi, Y. Sekine, M. Iyo, M. Harano, T. Komiyama, M. Yamada, I. Sora, H. Ujike, T. Inada, and N. Iwata. Possible association of β‐arrestin 2 gene with methamphetamine use disorder, but not schizophrenia. Genes, Brain and Behavior, 6(1):107–112, April 2006. URL: http://dx.doi.org/10.1111/j.1601-183x.2006.00237.x, doi:10.1111/j.1601-183x.2006.00237.x. This article has 24 citations.](https://doi.org/10.1111/j.1601-183x.2006.00237.x)

[6. (Sun2007βArrestins) D Sun, J Z Ma, T J Payne, and M D Li. Β-arrestins 1 and 2 are associated with nicotine dependence in european american smokers. Molecular Psychiatry, 13(4):398–406, June 2007. URL: http://dx.doi.org/10.1038/sj.mp.4002036, doi:10.1038/sj.mp.4002036. This article has 30 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/sj.mp.4002036)

[7. (Oneda2010βArrestin2) B Oneda, S Crettol, M Bochud, J Besson, M Croquette-Krokar, R Hämmig, M Monnat, M Preisig, and C B Eap. Β-arrestin2 influences the response to methadone in opioid-dependent patients. The Pharmacogenomics Journal, 11(4):258–266, June 2010. URL: http://dx.doi.org/10.1038/tpj.2010.37, doi:10.1038/tpj.2010.37. This article has 29 citations.](https://doi.org/10.1038/tpj.2010.37)

[8. (Petit2018The) Anne-Cécile Petit, Khalil El Asmar, Denis J. David, Alain M. Gardier, Laurent Becquemont, Bruno Fève, Céline Verstuyft, and Emmanuelle Corruble. The association of β-arrestin2 polymorphisms with response to antidepressant treatment in depressed patients. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 81:74–79, February 2018. URL: http://dx.doi.org/10.1016/j.pnpbp.2017.10.006, doi:10.1016/j.pnpbp.2017.10.006. This article has 8 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.pnpbp.2017.10.006)

[9. (Peterson2017The) Yuri K. Peterson and Louis M. Luttrell. The diverse roles of arrestin scaffolds in g protein–coupled receptor signaling. Pharmacological Reviews, 69(3):256–297, June 2017. URL: http://dx.doi.org/10.1124/pr.116.013367, doi:10.1124/pr.116.013367. This article has 421 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1124/pr.116.013367)

[10. (Wang2017βarrestin) Yimei Wang, Li Jin, Ying Song, Mao Zhang, Dan Shan, Yuli Liu, Meng Fang, Fengxiang Lv, Rui-Ping Xiao, and Yan Zhang. Β-arrestin 2 mediates cardiac ischemia-reperfusion injury via inhibiting gpcr-independent cell survival signalling. Cardiovascular Research, 113(13):1615–1626, August 2017. URL: http://dx.doi.org/10.1093/cvr/cvx147, doi:10.1093/cvr/cvx147. This article has 28 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1093/cvr/cvx147)

[11. (Scott2002Differential) Mark G.H. Scott, Erwann Le Rouzic, Axel Périanin, Vincenzo Pierotti, Hervé Enslen, Serge Benichou, Stefano Marullo, and Alexandre Benmerah. Differential nucleocytoplasmic shuttling of β-arrestins. Journal of Biological Chemistry, 277(40):37693–37701, October 2002. URL: http://dx.doi.org/10.1074/jbc.m207552200, doi:10.1074/jbc.m207552200. This article has 176 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.m207552200)

[12. (Reiter2017βarrestin) Eric Reiter, Mohammed Akli Ayoub, Lucie P. Pellissier, Flavie Landomiel, Astrid Musnier, Aurélie Tréfier, Jorge Gandia, Francesco De Pascali, Shifa Tahir, Romain Yvinec, Gilles Bruneau, Anne Poupon, and Pascale Crépieux. Β-arrestin signalling and bias in hormone-responsive gpcrs. Molecular and Cellular Endocrinology, 449:28–41, July 2017. URL: http://dx.doi.org/10.1016/j.mce.2017.01.052, doi:10.1016/j.mce.2017.01.052. This article has 36 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.mce.2017.01.052)

[13. (Bae2021βarrestin) Woom-Yee Bae, Jae-Sun Choi, Seungyoon Nam, and Joo-Won Jeong. Β-arrestin 2 stimulates degradation of hif-1α and modulates tumor progression of glioblastoma. Cell Death &amp; Differentiation, 28(11):3092–3104, May 2021. URL: http://dx.doi.org/10.1038/s41418-021-00802-2, doi:10.1038/s41418-021-00802-2. This article has 17 citations.](https://doi.org/10.1038/s41418-021-00802-2)

[14. (Walker2003βArrestin2) Julia K.L. Walker, Alan M. Fong, Barbara L. Lawson, Jordan D. Savov, Dhavalkumar D. Patel, David A. Schwartz, and Robert J. Lefkowitz. Β-arrestin-2 regulates the development of allergic asthma. Journal of Clinical Investigation, 112(4):566–574, August 2003. URL: http://dx.doi.org/10.1172/jci17265, doi:10.1172/jci17265. This article has 5 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1172/jci17265)